Each launch has a million moving pieces. Almost all are based on what
you know about your market. Which patients are using which products? What is
their patient journey? What types of physicians prescribe them? How do
treatments and costs vary by geography or provider? Primary market research
provides some of the picture. Now, advanced analytics, including machine
learning, and IQVIA’s diverse portfolio of 530 million anonymous patient
records, can change the game. You can gain a much needed, more precise understanding
of your market today and where it is going.
Use data-based patient
journeys that tell you what patients and physicians do, so you can ask
them why.
Simplify analyses and get a
quick view of new-to-brand activity using National Brand Performance
(NBRx), a summarized metric that combines new therapy starts, switches and
add-ons. NBRx leverages both rich longitudinal prescription data and
non-identified EMR data.
Apply insights to predict
future market share and launch curves. Adjust your plans and resource
allocation to meet expected forecasts.
.png)
CH
